Key Drivers
- High cash generation
- Negative profitability
- Moderate leverage
AIAI Summary
Treat Centene as a margin-recovery and policy-risk trade rather than a pure scale growth name: the investment hinges on demonstrable HBR improvement and delivery of adjusted EPS >$3 (driven by successful Marketplace repricing and SG&A discipline) because failure would likely trigger further impairments and continued multiple compression. Actionable triggers to watch: quarterly adjusted EPS vs guidance, consolidated HBR trends, Marketplace Silver share/pricing, and technical validation at $34.4 support or a sustained move back above the mid-$40s.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High cash generation
- •Negative profitability
- •Moderate leverage
Centene delivers strong scale and cash generation (revenue $194.8B, FCF $4.32B, $17.9B cash) but is weighed down by persistent operating losses, thin margins, and limited near-term liquidity cushion.
Price Behavior
Key Price Behavior Insights:
- •Strong selling
- •Defined support
- •High volatility
Over the last month the stock is in a clear downtrend—down ~20% to $34.40 with key support at $34.40 that must hold to prevent further losses and resistance in the low‑to‑mid $40s (~$44.90) needed to negate the downtrend.
Very sharp event‑driven drop between 2026-03-09 and 2026-03-10 increased volatility
Sentiment & News
Key News Insights:
- •Membership decline
- •Stock sell‑off
- •Community investments
Centene faces investor pressure from declining ACA membership and operational issues that spurred a sharp sell‑off even as it continues substantial community and housing investments.
Near‑term downside risk remains until enrollment trends stabilize, though continued social investments may help longer‑term reputation and stakeholder support
Similar Companies in Healthcare
Other companies in the same sector with AI ratings